Buscar
Mostrando ítems 1-10 de 396
Modified vaccinia virus Ankara as vaccine vectors in human and veterinary medicine
(Future Medicine Ltd, 2015)
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
(2023)
Respiratory syncytial virus (RSV) is responsible for a significant proportion of global morbidity and mortality affecting young children and older adults. In the aftermath of formalin-inactivated RSV vaccine development, ...
Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids
(Taylor & Francis, 2019-01)
Foot and mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals, which causes severe economic losses in the livestock industry. Currently available vaccines are based on inactivated FMD virus (FMDV). ...
New Approaches for the design of DNA vaccine vectors delivered by lactic acid bacteria
(MedCrave Group, 2017-12-05)
Lactic Acid Bacteria (LAB) have been bioengineered for mucosal delivery of prophylactic, pro-inflammatory and useful molecules that include bioactive peptides, cytokines, enzymes, allergens and DNA. One of the many benefits ...
Evaluation of the immune response to Anaplasma marginale MSP5 protein using a HSV-1 amplicon vector system or recombinant protein
(Elsevier, 2014-11)
Anaplasma marginale is an intraerythrocytic vector-borne infectious agent of cattle. Immunization with the current vaccine, based on parasitized erythrocytes with live Anaplasmacentrale, shows some constraints and confers ...
Designing recombinant MVAs as dual-antigen vector vaccines against SARS-CoV-2
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2021)
Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid proteins and boosted with inactivated virus
(Elsevier, 2013-08-30)
The aim of the present study was to assess the effect of introducing a priming step with replication-defective viral vectors encoding the capsid proteins of FMDV, followed by a boost with killed virus vaccines, using a ...
Target cells for antibodies detection in rabies vaccine control
(Elsevier, 2014-03)
Rabies causes one of the most lethal zoonotic diseases, with more than 55,000 deaths reported annually. Prevention is based on pre‑exposure vaccination of individuals at high risk of contracting rabies, and mass vaccination ...
SARS-CoV-2 Vaccine development: Current Status
In the midst of the SARS-CoV-2 pandemic and its attendant morbidity and mortality, safe
and efficacious vaccines are needed that induce protective and long-lived immune responses.
Over 120 vaccine candidates worldwide ...